Paliperidone Eg 150 Mg

Paliperidone, the active ingredient in Paliperidone Eg 150 Mg, is a atypical antipsychotic presented as a 150 mg oral tablet for oral use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adults.

GNH USA supplies Paliperidone Eg 150 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidone is an atypical antipsychotic that modulates dopamine and serotonin pathways in psychotic disorders. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Schizoaffective disorder: Controls mood swings and psychotic features. - Maintenance therapy: Supports long‑term stability after acute symptom control.

Adverse reactions to paliperidone vary in frequency and severity.

Common Side Effects: - Akathisia: Restlessness and an urge to move. - Weight gain: Increased appetite leading to modest weight increase. - Somnolence: Drowsiness or fatigue. - Dry mouth: Reduced salivation. - Constipation: Decreased bowel motility. - Extrapyramidal symptoms: Tremor, rigidity, or bradykinesia.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: Life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: Persistent involuntary movements. - Seizures: Increased risk, especially at higher doses. - Orthostatic hypotension: Sudden drop in blood pressure upon standing. - Hyperglycaemia: Elevated blood glucose levels. - QT prolongation: Potential cardiac rhythm disturbance.

When prescribing paliperidone, clinicians should consider several safety aspects. - Cardiac monitoring: Baseline and periodic ECGs for patients with cardiac risk factors. - Metabolic assessment: Monitor weight, glucose, and lipid levels regularly. - CNS effects: Evaluate for signs of sedation, dizziness, or movement disorders. - Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus. - Renal function: Adjust dose in patients with impaired kidney function. - Store at ambient temperature: Keep below 25 °C in the original packaging, protected from moisture.

Paliperidone may interact with other medicines, requiring attention to the interaction severity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase paliperidone plasma levels. - CNS depressants (e.g., benzodiazepines): May enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Antihypertensives: May potentiate orthostatic hypotension. - Anticholinergic agents: May worsen dry mouth and constipation. - Lithium: May increase risk of neurotoxic effects. - NSAIDs: May raise the risk of bleeding when combined with antiplatelet therapy.